Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mutations01:39

Mutations

94.4K
Overview
94.4K
Mutations01:35

Mutations

44.5K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.5K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

64.0K
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.9K
Viral Mutations00:36

Viral Mutations

39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Random Error01:04

Random Error

9.8K
Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...
9.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predicting protein cascade expression from H&E images.

PLoS computational biology·2026
Same author

Gene-Morphology Alignment via Graph-Constrained Latent Modeling for Molecular Subtype Prediction from Histopathology in Pancreatic Cancer.

medRxiv : the preprint server for health sciences·2026
Same author

Performance of Naiive Spectral Geometric Models in Histopathology AI.

bioRxiv : the preprint server for biology·2026
Same author

Neural Networks as Entropic Systems: Applications in Digital Pathology.

bioRxiv : the preprint server for biology·2026
Same author

Predicting Protein Cascade Expression from H&E Images.

medRxiv : the preprint server for health sciences·2026
Same author

Spatial Regression of Morphology-Protein Coupling in Tumour Proteomics.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: Jan 29, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.8K

关于确定癌症突变是功能性的还是随机的

Alejandro Leyva1, Muhammad Khalid Khan Niazi2

  • 1Department of Biomedical Engineering, The Ohio State University, 2255 Kenny Rd., Colombus, OH 43210, USA.

Genes
|January 28, 2026
PubMed
概括
此摘要是机器生成的。

这项研究引入了代码子意识中性建模,以区分致癌突变与随机遗传变化. 这种新方法有助于通过分析TP53和PIK3CA突变的进化模式来解释未知意义的遗传变异.

关键词:
这就是Blossom.蒙特卡洛模拟的蒙特卡洛模拟这就是PIK3CA.这就是TP53的特点.癌症基因组学 癌症基因组学这是一个codon-aware模型.中立进化是中立的进化.身体突变是一种体质突变.

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.8K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K

相关实验视频

Last Updated: Jan 29, 2026

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
09:53

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

11.8K
Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
12:04

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

4.8K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

15.2K

科学领域:

  • 基因组学就是基因组学.
  • 癌症生物学 癌症生物学
  • 进化遗传学 进化遗传学

背景情况:

  • 基因突变是癌症发展的核心.
  • 目前用于分析突变的方法,如WXS测序和BLOSUM评分,不能完全考虑基对的变化或将突变置于中性进化过程中的背景.
  • 在临床环境中解释未知意义的变异是具有挑战性的,因为难以区分致癌选择和随机突变降解.

研究的目的:

  • 开发和验证一种新型模型,将进化保护与基对变化概率相结合.
  • 为了评估观察到的突变与codon-aware中性预期的偏差.
  • 通过区分选择和随机过程来改善癌症遗传变异的解释.

主要方法:

  • 从TCGA BRCA队列中分析突变序列,重点关注TP53和PIK3CA基因.
  • 开发一个模型,将BLOSUM评分与基数对变化的统计建模结合起来.
  • 将观察到的突变分布与中性模型进行比较,以使用基平方测试来确定统计学意义.

主要成果:

  • 在TCGA BRCA队列中的TP53突变显示出明显更为激进的进化变化,而不是由代码子意识中性模型预测.
  • 与中性期望相比,PIK3CA突变表现出明显更保守的进化模式.
  • 这些对立的模式与TP53 (瘤抑制剂) 和PIK3CA (瘤基因) 在癌症中的不同作用一致,反映了选择压力.

结论:

  • 具有Codon意识的中性建模提供了一个统计框架,以识别与随机预期分离的突变.
  • 这种方法可以通过将突变严重程度置于背景下来帮助解释未知意义的变异.
  • 该模型提供了对瘤演变的洞察力,并可能有助于预后评估,而不需要预先建立的基因水平中立性假设.